Photo from Vinay Prasad/Twitter
Mar 5, 2024, 01:20
Vinay Prasad: A scoping review of all 2:1, 3:1, etc randomization ratios
Vinay Prasad, Professor of Epidemiology and Biostatistics at the University of California, San Francisco, shared a post on X:
“Just out in Contemporary Clinical Trials!
We performing a scoping review of all 2:1, 3:1, etc randomization ratios
Worth a read
Joshua emailed me from WSU Pullman med school and we now have several papers coming after zoom collaboration.”
Read further.
Source: Vinay Prasad/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 9, 2025, 18:18
Sep 9, 2025, 17:59
Sep 9, 2025, 17:43
Sep 9, 2025, 16:51
Sep 9, 2025, 15:59